The Daily Biotech Pulse: Illumina Announces Multiple Partnerships, Immunome Slides On Regulatory Setback For COVID Antibody Drug, Preannouncements Pour In
Here's a roundup of top developments in the biotech space over the last 24 hours:
Natus Medical Q3 EPS $0.28 Misses $0.34 Estimate, Sales $113.90M Miss $116.80M Estimate
Natus Medical (NASDAQ:NTUS) reported quarterly earnings of $0.28 per share which missed the analyst consensus estimate of $0.34 by 17.65 percent. This is a 211.11 percent increase over earnings of $0.09 per share from
Earnings Scheduled For November 4, 2021
Companies Reporting Before The Bell
• DISH Network (NASDAQ:DISH) is likely to report quarterly earnings at $0.91 per share on revenue of $4.45 billion.
Return on Capital Employed Overview: Natus Medical
After pulling data from Benzinga Pro it seems like during Q2, Natus Medical (NASDAQ:NTUS) earned $6.01 million, a 33.05% increase from the preceding quarter.
Natus Medical Q2 EPS $0.29 Beats $0.25 Estimate, Sales $116.00M Beat $114.00M Estimate
Natus Medical (NASDAQ:NTUS) reported quarterly earnings of $0.29 per share which beat the analyst consensus estimate of $0.25 by 16 percent. This is a 323.08 percent increase over losses of $(0.13) per share from the
Earnings Scheduled For August 5, 2021
Companies Reporting Before The Bell
• OneSpaWorld Holdings (NASDAQ:OSW) is projected to report quarterly loss at $0.20 per share on revenue of $6.42 million.
The Daily Biotech Pulse: Orphazyme Falters At FDA, Athira’s CEO Placed On Temporary Leave, 5 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs June 17)
Earnings Scheduled For May 6, 2021
Companies Reporting Before The Bell
• ViacomCBS (NASDAQ:VIAC) is projected to report quarterly earnings at $1.22 per share on revenue of $7.30 billion.